Northern Dynasty Minerals (AMEX:NAK) reported quarterly losses of $(0.01) per share. This is a 60 percent increase over losses of $(0.02) per share from the same period last year.
Acadia Pharma’s Rett Syndrome Drug Becomes First FDA-Approved Treatment
The FDA has approved Acadia Pharmaceuticals Inc’s (NASDAQ:ACAD) Daybue (trofinetide) for Rett syndrome in adult and pediatric patients two years of…
